Tag: in situ hybridization market forecast

Uncover key drivers, emerging technologies, and competitive movements shaping the in-situ hybridization market from 2025–2034 with trusted insights from The Business Research Company

How Big Is The In-Situ Hybridization Market Size Today And What Will Its Value Be At The End Of 2029?

The in situ hybridization market has seen strong growth in recent years. It is projected to expand from $1.68 billion in 2024 to $1.81 billion in 2025, achieving a compound annual growth rate (CAGR) of 8.1%. The growth observed in the historic period can be attributed to factors such as early adoption in research, the evolution of molecular biology tools, the development of diagnostic applications, a shift in biomedical research focus, and increasing investment in biotechnology.

The in situ hybridization market is poised for significant expansion in the coming years. Projections indicate a rise to $2.76 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.1%. This anticipated growth during the forecast period is driven by factors such as increased integration into clinical diagnostics, an uptick in research and development funding, the emergence of automation and high-throughput solutions, and broader applications across neuroscience and pathology. Key trends anticipated during this period encompass progress in molecular biology, escalating demand within research applications, an expansion of diagnostic uses, the growing need for personalized medicine, and enhanced financial support for biomedical research.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24571&type=smp

Which Key Drivers Are Powering Growth In The In-Situ Hybridization Market?

The in-situ hybridization market is anticipated to experience growth as infectious diseases become more common. These conditions are characterized by their transmission from one person to another through contaminated food and beverages, or by pathogens such as viruses, bacteria, fungi, and parasites. In situ hybridization (ISH) plays a role by identifying complementary nucleic acid sequences within tissues, utilizing labeled nucleic acid sequences (probes) specific to the infectious organism, thus driving the expansion of the in-situ hybridization market due to increasing infectious diseases. For illustration, the Centers for Disease Control and Prevention, a US-based government agency, reported in March 2024 that tuberculosis cases climbed from 8,320 in 2022 to 9,615 in 2023, an increase of 1,295 cases. This demonstrates how the escalation of infectious diseases is indeed stimulating the development of the in-situ hybridization market.

Which Segment Categories Are Driving Maximum Growth In The In-Situ Hybridization Market?

The in situ hybridizationmarket covered in this report is segmented –

1) By Product: Analytical Instruments, Kits and Reagents, Software and Services, Other Products

2) By Technique: Fluorescence In Situ Hybridization (FISH), Chromogenic In Situ hybridization (CISH)

3) By Probe: Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA)

4) By Application: Cancer, Cytogenetics, Developmental Biology, Infectious Diseases, Other Applications

5) By End Use: Research And Diagnostic Laboratories, Contract Research Organization (CROs), Academic Institutes, Other End Uses

Subsegments:

1) By Analytical Instruments: Fluorescence Microscopes, Imaging Systems, Hybridization Systems

2) By Kits and Reagents: Hybridization Kits, Detection Kits, Probes And Reagents

3) By Software and Services: Image Analysis Software, Data Management Software, Consulting And Support Services

4) By Other Products: Accessories, Control Samples, Maintenance Supplies

What Key Trends Are Driving Growth In The In-Situ Hybridization Market?

Leading companies in the in situ hybridization market are focused on creating innovative solutions, such as RNA detection assays, to advance the development of gene therapy. An RNA detection assay is a molecular technique used to identify and quantify specific RNA molecules in a sample, facilitating the study of gene expression, viral infections, and other RNA-related biological processes. For instance, in January 2023, Bio-Techne Corporation, a US-based life sciences company, launched the RNAscope Plus smRNA-RNA detection assay. This RNAscope Plus smRNA-RNA detection assay is an advanced in situ hybridization tool designed for the simultaneous fluorescent detection of small regulatory RNAs, like microRNAs (miRNAs), along with three target RNAs or RNA biomarkers in the same tissue section. The assay offers single-cell and subcellular resolution, empowering researchers to effectively assess the biodistribution and functionality of innovative gene therapies and endogenous regulatory RNAs. It is built for scalability to support large studies and can be utilized on the Leica Bond Rx platform or as a manual assay. By integrating proprietary RNAscope and miRNAscope technologies, this assay significantly enhances the understanding of gene expression and cellular reactions, providing critical insights for developing customized gene therapies for inherited or acquired diseases.

Who Are The Leading Companies Driving The In-Situ Hybridization Market?

Major companies operating in the in situ hybridization market include Thermo Fisher Scientific Inc., Bio SB Inc., BioGenex Laboratories, Advanced Cell Diagnostics Inc., Exiqon A/S, Agilent Technologies Inc., F. Hoffmann-La Roche AG, Abbott Laboratories Inc., Merck KGaA, PerkinElmer Inc., Biocare Medical LLC, Genemed Biotechnologies, Danaher Corporation, Leica Biosystems Nussloch GmbH, Bio-Rad Laboratories Inc., Oxford Gene Technology, Abnova Corporation, Qiagen, Bio-Techne Corporation, Biochain Institute Inc., Cytocell Ltd., Enzo Life Sciences Inc., Eurofins Scientific SE, FISH Technologies Sdn Bhd, Genetix Biotech Asia Pvt. Ltd., Zytomed System GmbH, Akoya Biosciences Inc., Becton Dickinson and Company (BD), DAKO Systemtechnik und Service GmbH & Co, Molecular Devices LLC., NanoString Technologies Inc., Visiopharm A/S

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/in-situ-hybridization-global-market-report

Which Region Holds The Largest Share In The In-Situ Hybridization Market Today?

North America was the largest region in the in situ hybridization market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global in situ hybridization market during the forecast period. The regions covered in the in situ hybridization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=24571&type=smp

Browse Through More Reports Similar to the Global In-Situ Hybridization Market 2025, By The Business Research Company

Hybrid Cloud Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hybrid-cloud-global-market-report

Hybrid Valve Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hybrid-valve-global-market-report

Hybrid Composites Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hybrid-composites-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The In-Situ Hybridization Market By 2029?

The valuation of the in situ hybridization market has experienced a robust upward trajectory throughout the preceding years, projected to expand from a figure of 1.68 billion USD in the current year of 2024 to reach 1.81 billion USD by the subsequent year, 2025, reflecting an aggregate yearly expansion rate (CAGR) computed at 8.1%; this expansion seen during the historical phase is largely a consequence of initial acceptance within research settings, advancements in the instrumentation available for molecular biology, the maturation of new uses in diagnostics, a reorientation of priorities in the field of biomedical investigations, and augmented capital allocation toward the biotechnology sector.

Forecasting substantial expansion, the market centered around in situ hybridization is projected to experience swift ascent, reaching a valuation of $2.76 billion by the year 2029, driven by an anticipated compound annual growth rate of 11.1%; this upswing over the coming period is largely fueled by the greater utilization within clinical diagnostic procedures, augmenting financial support for research and development initiatives, the proliferation of automated and high-throughput systems, and the broadening scope of its utility across fields like neuroscience and pathology, while key developments shaping this era encompass sophisticated progress within molecular biology, escalating the need for its role in research activities, the widening sphere of its diagnostic uses, the call for tailored medical treatments, and heightened investment flowing into biomedical investigations.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24571&type=smp

Which Industry Drivers Are Expected To Accelerate The In-Situ Hybridization Market From 2025 To 2029?

The escalating prevalence of contagious illnesses is projected to be the primary catalyst for expansion within the in-situ hybridization market moving ahead. These conditions, spread between people through contaminated sustenance and drinks, are caused by microscopic agents like viruses, bacteria, fungi, and parasites. In-situ hybridization (ISH) operates by employing traceable nucleic acid segments, known as probes, which are specifically designed to bind with matching nucleic acid sequences present within tissue samples; consequently, the surge in infectious disease occurrences directly fuels the advancement of the ISH market. A concrete illustration of this trend is provided by the Centers for Disease Control and Prevention, establishing that tuberculosis incidence in the US grew by 1,295 instances, climbing from 8,320 cases in 2022 to 9,615 cases in 2023, as reported in March 2024, thus demonstrating how the rise in infectious diseases is lending momentum to the in-situ hybridization market’s progression.

What Are The Emerging Segments Gaining Attention In The In-Situ Hybridization Market?

The in situ hybridizationmarket covered in this report is segmented –

1) By Product: Analytical Instruments, Kits and Reagents, Software and Services, Other Products

2) By Technique: Fluorescence In Situ Hybridization (FISH), Chromogenic In Situ hybridization (CISH)

3) By Probe: Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA)

4) By Application: Cancer, Cytogenetics, Developmental Biology, Infectious Diseases, Other Applications

5) By End Use: Research And Diagnostic Laboratories, Contract Research Organization (CROs), Academic Institutes, Other End Uses

Subsegments:

1) By Analytical Instruments: Fluorescence Microscopes, Imaging Systems, Hybridization Systems

2) By Kits and Reagents: Hybridization Kits, Detection Kits, Probes And Reagents

3) By Software and Services: Image Analysis Software, Data Management Software, Consulting And Support Services

4) By Other Products: Accessories, Control Samples, Maintenance Supplies

What Trends Are Expected To Drive The In-Situ Hybridization Market?

Key players within the realm of in situ hybridization are concentrating their efforts on pioneering novel advancements, notably in the creation of RNA detection assays, which are crucial for propelling gene therapy progress. An RNA detection assay constitutes a sophisticated molecular method employed for both locating and determining the amount of distinct RNA molecules present in a given specimen, thereby facilitating investigations into gene expression patterns, viral invasions, and other biological phenomena involving RNA. For example, in the month of January 2023, Bio-Techne Corporation, a biotechnology firm situated in the United States, introduced the RNAscope Plus smRNA-RNA detection assay; this represents an evolved in situ hybridization instrument capable of allowing researchers to concurrently visualize, via fluorescence, minute regulatory RNAs like microRNAs (miRNAs) alongside three distinct target RNAs or RNA biomarkers within one tissue substrate. Offering resolution down to the single-cell and subcellular levels, this technology empowers scientists to accurately evaluate how new gene therapies and native regulatory RNAs distribute biologically and perform functionally. Its architecture supports scaling up for extensive research undertakings and it maintains compatibility for use either manually or on the Leica Bond Rx system. Through the successful combination of the established RNAscope and miRNAscope platforms, this particular assay substantially enhances comprehension of how genes are expressed and how cells respond, furnishing essential knowledge necessary for crafting personalized gene therapies aimed at both congenital and acquired ailments.

Who Are The Top Performing Companies In The In-Situ Hybridization Market In Recent Years?

Major companies operating in the in situ hybridization market include Thermo Fisher Scientific Inc., Bio SB Inc., BioGenex Laboratories, Advanced Cell Diagnostics Inc., Exiqon A/S, Agilent Technologies Inc., F. Hoffmann-La Roche AG, Abbott Laboratories Inc., Merck KGaA, PerkinElmer Inc., Biocare Medical LLC, Genemed Biotechnologies, Danaher Corporation, Leica Biosystems Nussloch GmbH, Bio-Rad Laboratories Inc., Oxford Gene Technology, Abnova Corporation, Qiagen, Bio-Techne Corporation, Biochain Institute Inc., Cytocell Ltd., Enzo Life Sciences Inc., Eurofins Scientific SE, FISH Technologies Sdn Bhd, Genetix Biotech Asia Pvt. Ltd., Zytomed System GmbH, Akoya Biosciences Inc., Becton Dickinson and Company (BD), DAKO Systemtechnik und Service GmbH & Co, Molecular Devices LLC., NanoString Technologies Inc., Visiopharm A/S

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/in-situ-hybridization-global-market-report

What Regional Growth Trends Are Shaping The In-Situ Hybridization Market Outlook?

North America was the largest region in the in situ hybridization market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global in situ hybridization market during the forecast period. The regions covered in the in situ hybridization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The In-Situ Hybridization Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24571&type=smp

Browse Through More Reports Similar to the Global In-Situ Hybridization Market 2025, By The Business Research Company

Hybrid Cloud Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hybrid-cloud-global-market-report

Hybrid Valve Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hybrid-valve-global-market-report

Hybrid Composites Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hybrid-composites-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

#How Much Will The In-Situ Hybridization Market Be Worth By 2029?#_x000D_

In recent years, the in situ hybridization market has been experiencing robust growth. It is predicted to expand from $1.68 billion in 2024 to $1.81 billion in 2025, with a compound annual growth rate (CAGR) of 8.1%. Factors contributing to this growth during the historical period include the early adoption in research activities, the advancement of molecular biology tools, the growth in the development of diagnostic applications, a change in focus in biomedical research, and a rise in biotechnology investments._x000D_

_x000D_

The market size for in situ hybridization is projected to witness substantial growth in the coming years. It’s anticipated to reach $2.76 billion by 2029 with a compound annual growth rate (CAGR) of 11.1%. The expansion during the forecast period is due to its heightened use in clinical diagnostics, increases in research and development funds, automation, and solutions for high throughput, as well as larger application scopes in neuroscience and pathology. The forecast period will also see significant trends like advancements in molecular biology, growing need in research applications, expansion of diagnostic applications, demand for custom-made medicine, and surges in financial support for biomedical research._x000D_

_x000D_

#Get A Free Sample Of The Report:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=24571&type=smp_x000D_

_x000D_

#What External And Internal Drivers Are Influencing The In-Situ Hybridization Market?#_x000D_

The surge in infectious diseases is anticipated to fuel the expansion of the in-situ hybridization market. These diseases, which can be spread from one person to another through contaminated food and drinks, and via pathogens like viruses, bacteria, fungi, and parasites, are recognized by in-situ hybridization (ISH) through the use of labeled nucleic acid sequences or probes specific to the infectious organism. They find complementary nucleic acid sequences within the tissue, thus, the rise in infectious diseases contributes to the growth of the in-situ hybridization market. To illustrate, the Centers for Disease Control and Prevention, a U.S. government agency, reported in March 2024 that tuberculosis cases climbed from 8,320 in 2022 to 9,615 in 2023, an increase of 1,295 instances. Hence, the rise in infectious diseases is a significant driving factor for the advancement of the in-situ hybridization market._x000D_

_x000D_

#What Segmentation Insights Are Provided In The In-Situ Hybridization Market Research?#_x000D_

The in situ hybridizationmarket covered in this report is segmented –_x000D_

_x000D_

1) By Product: Analytical Instruments, Kits and Reagents, Software and Services, Other Products_x000D_

2) By Technique: Fluorescence In Situ Hybridization (FISH), Chromogenic In Situ hybridization (CISH)_x000D_

3) By Probe: Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA)_x000D_

4) By Application: Cancer, Cytogenetics, Developmental Biology, Infectious Diseases, Other Applications_x000D_

5) By End Use: Research And Diagnostic Laboratories, Contract Research Organization (CROs), Academic Institutes, Other End Uses_x000D_

_x000D_

Subsegments:_x000D_

1) By Analytical Instruments: Fluorescence Microscopes, Imaging Systems, Hybridization Systems_x000D_

2) By Kits and Reagents: Hybridization Kits, Detection Kits, Probes And Reagents_x000D_

3) By Software and Services: Image Analysis Software, Data Management Software, Consulting And Support Services_x000D_

4) By Other Products: Accessories, Control Samples, Maintenance Supplies_x000D_

_x000D_

#Which Notable Trends Are Transforming The In-Situ Hybridization Market Outlook?#_x000D_

Key businesses in the in situ hybridization market are concentrating their efforts on creating innovative solutions like RNA detection assays to further genetic therapy development. RNA detection assays are a molecular method used to identify and measure specific RNA molecules present in a sample. They play a crucial role in studying gene expression, viral infections, and other RNA-associated biological processes. For example, in January 2023, Bio-Techne Corporation, a life sciences organization based in the United States, introduced the RNAscope Plus smRNA-RNA detection assay. An advanced in situ hybridization instrument, this assay allows for the simultaneous fluorescent detection of small regulating RNAs including microRNAs (miRNAs), plus three target RNAs or RNA biomarkers within the identical tissue portion. Offering single-cell and subcellular resolution, this assay equips researchers with the capability to effectively investigate the biodistribution and functional aspects of innovative gene therapies and endogenous regulatory RNAs. It can also cater to large-scale studies thanks to its design and is compatible with the Leica Bond Rx platform, as well as manual assays. By incorporating unique RNAscope and miRNAscope technologies, this assay helps in substantially improving the understanding of gene expression and cellular responses, thus providing essential data for creating personalized gene therapies for inherited or acquired disorders._x000D_

_x000D_

#Who Are The Leading Companies Driving The In-Situ Hybridization Market?#_x000D_

Major companies operating in the in situ hybridization market include Thermo Fisher Scientific Inc., Bio SB Inc., BioGenex Laboratories, Advanced Cell Diagnostics Inc., Exiqon A/S, Agilent Technologies Inc., F. Hoffmann-La Roche AG, Abbott Laboratories Inc., Merck KGaA, PerkinElmer Inc., Biocare Medical LLC, Genemed Biotechnologies, Danaher Corporation, Leica Biosystems Nussloch GmbH, Bio-Rad Laboratories Inc., Oxford Gene Technology, Abnova Corporation, Qiagen, Bio-Techne Corporation, Biochain Institute Inc., Cytocell Ltd., Enzo Life Sciences Inc., Eurofins Scientific SE, FISH Technologies Sdn Bhd, Genetix Biotech Asia Pvt. Ltd., Zytomed System GmbH, Akoya Biosciences Inc., Becton Dickinson and Company (BD), DAKO Systemtechnik und Service GmbH & Co, Molecular Devices LLC., NanoString Technologies Inc., Visiopharm A/S_x000D_

_x000D_

#Access The Complete Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/in-situ-hybridization-global-market-report_x000D_

_x000D_

#Which Geographic Regions Are Creating Strong Demand In The In-Situ Hybridization Market?#_x000D_

North America was the largest region in the in situ hybridization market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global in situ hybridization market during the forecast period. The regions covered in the in situ hybridization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Customize Your Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=24571&type=smp_x000D_

_x000D_

Browse Through More Reports Similar to the Global In-Situ Hybridization Market 2025, By The Business Research Company_x000D_

_x000D_

Hybrid Cloud Global Market Report 2025_x000D_

https://www.thebusinessresearchcompany.com/report/hybrid-cloud-global-market-report_x000D_

_x000D_

Hybrid Valve Global Market Report 2025_x000D_

https://www.thebusinessresearchcompany.com/report/hybrid-valve-global-market-report_x000D_

_x000D_

Hybrid Composites Global Market Report 2025_x000D_

https://www.thebusinessresearchcompany.com/report/hybrid-composites-global-market-report_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the In Situ Hybridization Market Growth Performance Trended Historically, And What Lies Ahead?

The market size for in situ hybridization has experienced significant expansion recently. Predicted to advance from $1.68 billion in 2024 to $1.81 billion in 2025, it exhibits a compound annual growth rate (CAGR) of 8.1%. The historic growth rate owes its momentum to factors such as early adoption in research, development of molecular biology tools, evolution in diagnostic applications, re-direction of biomedical research priorities, and a rise in biotechnology investment.

The market size of in situ hybridization is predicted to experience a quick expansion in the coming years. It’s estimated to reach $2.76 billion by 2029, with a compound annual growth rate (CAGR) of 11.1%. The escalation during the projected period could be due to its increased use in clinical diagnostics, the surge in research and development funds, the introduction of automation and high-capacity solutions, and its wider applications in neuroscience and pathology. Noteworthy trends for the forecast period encompass improvements in molecular biology, escalated demand in research applications, expansion of diagnostic applications, the increasing call for personalized medicine, alongside a rise in funds for biomedical research.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24571&type=smp

Which Primay Drivers Are Accelerating Growth in the In Situ Hybridization Market?

The expansion of the in-situ hybridization market is projected to be driven by the surge in infectious diseases. Such diseases, which can be spread through contaminated food and drink, as well as through pathogens like viruses, bacteria, fungi, and parasites, are identified via in-situ hybridization (ISH) utilizing specific labeled nucleic acid sequences or probes. As these diseases increase in prevalence, so too does the growth of the ISH market. For example, the Centers for Disease Control and Prevention, a US government agency, reported a rise in tuberculosis cases from 8,320 in 2022 to 9,615 in 2023, indicating an additional 1,295 cases recorded in March 2024. This rise in infectious diseases, thus, fuels the growth of the in-situ hybridization market.

Which Primary Segments of the In Situ Hybridization Market Are Driving Growth and Industry Transformations?

The in situ hybridizationmarket covered in this report is segmented –

1) By Product: Analytical Instruments, Kits and Reagents, Software and Services, Other Products

2) By Technique: Fluorescence In Situ Hybridization (FISH), Chromogenic In Situ hybridization (CISH)

3) By Probe: Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA)

4) By Application: Cancer, Cytogenetics, Developmental Biology, Infectious Diseases, Other Applications

5) By End Use: Research And Diagnostic Laboratories, Contract Research Organization (CROs), Academic Institutes, Other End Uses

Subsegments:

1) By Analytical Instruments: Fluorescence Microscopes, Imaging Systems, Hybridization Systems

2) By Kits and Reagents: Hybridization Kits, Detection Kits, Probes And Reagents

3) By Software and Services: Image Analysis Software, Data Management Software, Consulting And Support Services

4) By Other Products: Accessories, Control Samples, Maintenance Supplies

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=24571&type=smp

Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the In Situ Hybridization Market?# Market?

North America was the largest region in the in situ hybridization market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global in situ hybridization market during the forecast period. The regions covered in the in situ hybridization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Which Technological Trends Are Reshaping the In Situ Hybridization Industry Dynamics?

Leading firms in the in situ hybridization market are concentrating their efforts on creating novel solutions such as RNA detection assays to enhance the progression of gene therapy. RNA detection assays are molecular procedures designed to identify and measure specific RNA molecules in a sample. These assays facilitate the research of gene expression, viral infections, and other processes related to RNA. For example, in January 2023, Bio-Techne Corporation, a US-based life sciences enterprise, introduced the RNAscope Plus smRNA-RNA detection assay. This improved in situ hybridization tool allows for the concurrent fluorescent detection of small regulatory RNAs, like microRNAs (miRNAs), and three targeted RNAs or RNA biomarkers within the same section of tissue. The assay delivers single-cell and subcellular resolution, hence allowing scientists to accurately examine the biodistribution and effectiveness of new gene therapies and endogenous regulatory RNAs. It is also engineered for scalability to support substantial studies and can be employed on the Leica Bond Rx platform or as a manual assay. By incorporating proprietary RNAscope and miRNAscope technologies, the assay considerably boosts the comprehension of gene expression and cellular responses, providing vital information for the creation of specialized gene therapies for inherited or acquired diseases.

View the full report here:

https://www.thebusinessresearchcompany.com/report/in-situ-hybridization-global-market-report

What Parameters Are Used to Define the In Situ Hybridization Market?

In-situ hybridization refers to the method that enables the exact localization of a certain nucleic acid segment inside a histologic slice. In-situ hybridization is used for identifying sequences of nucleotides in tissues, including complete tissues, portions of tissues, and cells.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24571

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the In Situ Hybridization Market Size Changed, over the years?

In recent times, the in situ hybridization market has seen substantial growth. The market is predicted to expand from $1.68 billion in 2024 to $1.83 billion in 2025, indicating a Compound Annual Growth Rate (CAGR) of 8.9%. This growth observed in the historic period is the result of several factors including early adoption in research, advancements in molecular biology tools, the growth of diagnostic applications, a shift in focus within biomedical research, and an increase in biotechnology investments.

How Much Will the In Situ Hybridization Market Be Worth in 2029?

The market size for in situ hybridization is projected to expand considerably in the coming years, reaching a value of “$2.79 billion in 2029 with a compound annual growth rate (CAGR) of 11.2%. The surge during the forecasted period can be linked to its growing use in clinical diagnostics, increased funding for research and development, and the advent of automation and high-throughput solutions. Its broader applications in neuroscience and pathology also contribute to this growth. The anticipated trends within this forecasted timeframe encompass advances in molecular biology, increased demand in research applications, expansion in diagnostic applications, a growing demand for personalized medicine, and a rise in investment for biomedical research.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10476&type=smp

Which is the Largest Company in the In Situ Hybridization Market?

Major companies operating in the in situ hybridization market include Thermo Fisher Scientific Inc., Bio SB Inc., BioGenex Laboratories, Advanced Cell Diagnostics Inc., Exiqon A/S, Agilent Technologies Inc., F. Hoffmann-La Roche AG, Abbott Laboratories Inc., Merck KGaA, PerkinElmer Inc., Biocare Medical LLC, Genemed Biotechnologies, Danaher Corporation, Leica Biosystems Nussloch GmbH, Bio-Rad Laboratories Inc., Oxford Gene Technology, Abnova Corporation, Qiagen, Bio-Techne Corporation, Biochain Institute Inc., Cytocell Ltd., Enzo Life Sciences Inc., Eurofins Scientific SE, FISH Technologies Sdn Bhd, Genetix Biotech Asia Pvt. Ltd., Zytomed System GmbH, Akoya Biosciences Inc., Becton Dickinson and Company (BD), DAKO Systemtechnik und Service GmbH & Co, Molecular Devices LLC., NanoString Technologies Inc., Visiopharm A/S

What Are the Main Market Drivers in the In Situ Hybridization Industry?

A rise in infectious diseases is predicted to boost the development of the in-situ hybridization market. Infectious illnesses, which can be transmitted from one person to another through contaminated food, drink and pathogens such as viruses, bacteria, fungi, and parasites, are indicated here. In-situ hybridization (ISH) uses labeled nucleic acid sequences (probes) specific to the infectious agent, to identify matching nucleic acid sequences found in the tissue. Therefore, a surge in infectious diseases enhances the expansion of the in-situ hybridization market. For example, the Centers for Disease Control and Prevention, a government agency based in the US, reported an increase in tuberculosis cases from 8,320 in 2022 to 9,615 in 2023, an increase of 1,295 cases in March 2024. Therefore, it can be stated that the escalating incidence of infectious diseases is contributing to the growth of the in-situ hybridization market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10476&type=smp

How Is the In Situ Hybridization Market Segments Structured?

The in situ hybridization market covered in this report is segmented –

1) By Product: Analytical Instruments, Kits and Reagents, Software and Services, Other Products

2) By Technique: Fluorescence In Situ Hybridization (FISH), Chromogenic In Situ hybridization (CISH)

3) By Probe: Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA)

4) By Application: Cancer, Cytogenetics, Developmental Biology, Infectious Diseases, Other Applications

5) By End Use: Research And Diagnostic Laboratories, Contract Research Organization (CROs), Academic Institutes, Other End Uses

Subsegments:

1) By Analytical Instruments: Fluorescence Microscopes, Imaging Systems, Hybridization Systems

2) By Kits and Reagents: Hybridization Kits, Detection Kits, Probes And Reagents

3) By Software and Services: Image Analysis Software, Data Management Software, Consulting And Support Services

4) By Other Products: Accessories, Control Samples, Maintenance Supplies

What Strategic Trends Are Transforming the In Situ Hybridization Market?

Leading firms in the in situ hybridization market are investing in the creation of innovative solutions like RNA detection assays to bolster the progress of gene therapy. RNA detection assays are molecular methods that aid in the recognition and quantification of distinct RNA molecules within a sample, facilitating research into gene expression, viral infections, and more. For example, Bio-Techne Corporation, a US-based life sciences firm, unveiled the RNAscope Plus smRNA-RNA detection assay in January 2023. This is a sophisticated in situ hybridization instrument that enables simultaneous fluorescent detection of small regulatory RNAs, such as microRNAs (miRNAs), and three target RNAs or RNA biomarkers within the same tissue section. The assay provides a single-cell and subcellular resolution, enabling scientists to efficiently examine the biodistribution and functionality of novel gene therapies and endogenous regulatory RNAs. This assay has been designed for large-scale studies and can be used on the Leica Bond Rx platform or as a manual assay. The assay, which combines proprietary RNAscope and miRNAscope technologies, greatly enhances comprehension of gene expression and cellular responses, providing crucial insights into the development of personalized gene therapies for inherited or acquired diseases.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/in-situ-hybridization-global-market-report

Which Global Regions Offer the Highest Growth in the In Situ Hybridization Market?

North America was the largest region in the in situ hybridization market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global in situ hybridization market during the forecast period. The regions covered in the in situ hybridization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10476

This Report Delivers Insight On:

1. How big is the in situ hybridization market, and how is it changing globally?

2. Who are the major companies in the in situ hybridization market, and how are they performing?

3. What are the key opportunities and risks in the in situ hybridization market right now?

4. Which products or customer segments are growing the most in the in situ hybridization market?

5. What factors are helping or slowing down the growth of the in situ hybridization market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the in situ hybridization industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What is the Anticipated CAGR of the In Situ Hybridization Market, and What Factors Will Drive It?#_x000D_

The market size of in situ hybridization has seen a significant increase in the past few years. The expectations are that it will expand from $1.68 billion in 2024 to $1.83 billion in 2025, with a compound annual growth rate (CAGR) of 8.9%. Factors such as early adoption in research, advancements in molecular biology tools, the evolution of diagnostic applications, change in focus of biomedical research, and increased investment in biotechnology contribute to the growth during the historic period._x000D_

_x000D_

The market for in situ hybridization is predicted to witness a high acceleration in the coming years, expanding to a projected worth of “$2.79 billion by 2029 with a compound annual growth rate (CAGR) of 11.2%. The growth during the projected period can be credited to its growing utilization in clinical diagnostics, increases in funding for research and development, the implementation of automation and high-capacity solutions, and its widening usage in fields like neuroscience and pathology. Key trends expected within this timeframe include progress within the molecular biology field, growing demand in research-related applications, an expansion in diagnostic applications, the rising need for personalized medicine, and a surge in funding for biomedical research._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=10476&type=smp_x000D_

_x000D_

#What Are the Primary Drivers Supporting the Market Growth of the In Situ Hybridization Market?#_x000D_

The surge in infectious diseases is projected to fuel the expansion of the in-situ hybridization market. These diseases, which can be transmitted from one person to another via contaminated foods, drinks or through pathogens such as viruses, bacteria, fungi, and parasites, have a direct impact on the in-situ hybridization market. This market employs labeled nucleic acid sequences, or probes, specific to the infectious organism to detect corresponding nucleic acid sequences in the tissue. Therefore, as the rate of infectious diseases escalates, so does the demand for in-situ hybridization. To illustrate, the Centers for Disease Control and Prevention, a government agency in the U.S., reported a jump in tuberculosis cases from 8,320 in 2022 to 9,615 in 2023, marking an increase of 1,295 cases in March 2024. This uptick in infectious diseases clearly propels the growth of the in-situ hybridization market._x000D_

_x000D_

#Which Primary Segments of the In Situ Hybridization Market Are Driving Growth and Industry Transformations?#_x000D_

The in situ hybridization market covered in this report is segmented –_x000D_

_x000D_

1) By Product: Analytical Instruments, Kits and Reagents, Software and Services, Other Products_x000D_

2) By Technique: Fluorescence In Situ Hybridization (FISH), Chromogenic In Situ hybridization (CISH)_x000D_

3) By Probe: Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA)_x000D_

4) By Application: Cancer, Cytogenetics, Developmental Biology, Infectious Diseases, Other Applications_x000D_

5) By End Use: Research And Diagnostic Laboratories, Contract Research Organization (CROs), Academic Institutes, Other End Uses_x000D_

_x000D_

Subsegments:_x000D_

1) By Analytical Instruments: Fluorescence Microscopes, Imaging Systems, Hybridization Systems_x000D_

2) By Kits and Reagents: Hybridization Kits, Detection Kits, Probes And Reagents_x000D_

3) By Software and Services: Image Analysis Software, Data Management Software, Consulting And Support Services_x000D_

4) By Other Products: Accessories, Control Samples, Maintenance Supplies_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=10476&type=smp_x000D_

_x000D_

#Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the In Situ Hybridization Market?# Market?#_x000D_

North America was the largest region in the in situ hybridization market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global in situ hybridization market during the forecast period. The regions covered in the in situ hybridization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#What Are the Most Significant Market Trends in the In Situ Hybridization Market?#_x000D_

Leading players in the in situ hybridization market are concentrating on creating groundbreaking solutions like RNA detection assays to enhance the progress of gene therapy. An RNA detection assay is a molecular approach used to identify and quantify specific RNA molecules in a sample, which facilitates studying gene expression, viral infections, and other RNA-associated biological functions. In January 2023, for example, Bio-Techne Corporation, a life sciences company from the US, introduced the RNAscope Plus smRNA-RNA detection assay. This advanced in situ hybridization tool can concurrently detect small regulatory RNAs, such as microRNAs (miRNAs), and three target RNAs or RNA biomarkers within the same tissue section. Designed for scalability, this assay can accommodate large studies and can be used on the Leica Bond Rx platform or manually. The assay offers single-cell and subcellular resolution, aiding researchers in evaluating the biodistribution and effectiveness of revolutionary gene therapies and native regulatory RNAs. By combining RNAscope and miRNAscope technologies, this assay significantly enhances our understanding of gene expression and cellular responses, providing key insights for creating personalized gene therapies for hereditary or acquired illnesses._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/in-situ-hybridization-global-market-report_x000D_

_x000D_

#What Parameters Are Used to Define the In Situ Hybridization Market?#_x000D_

In-situ hybridization refers to the method that enables the exact localization of a certain nucleic acid segment inside a histologic slice. In-situ hybridization is used for identifying sequences of nucleotides in tissues, including complete tissues, portions of tissues, and cells._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10476_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Major Innovations Are Driving the Accelerated Growth of the In Situ Hybridization Market?

The surge in infectious diseases is anticipated to stimulate the expansion of the in-situ hybridization market. These diseases are conditions that can be transmitted from one person to another via contaminated food and drinks and via microorganisms such as viruses, bacteria, fungi, and parasites. In-situ hybridization (ISH) uses labeled nucleic acid sequences or probes specific to the infectious organism to identify matching nucleic acid sequences within the tissue, thus a rise in infectious diseases spurs the in-situ hybridization market growth. For instance, in March 2024, the US-based government agency, Centers for Disease Control and Prevention, reported an increase in tuberculosis cases from 8,320 in 2022 to 9,615 in 2023, indicating a surge of 1,295 cases. Consequently, the escalating rates of infectious diseases are fueling the expansion of the in-situ hybridization market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10476&type=smp

#What is the Anticipated CAGR of theIn Situ Hybridization Market, and What Factors Will Drive It?

The market size for in situ hybridization has experienced substantial growth of late. The market will expand from $1.68 billion in 2024 to $1.83 billion in 2025, with a compound annual growth rate (CAGR) of 8.9%. This historical growth can be linked to its early application in research, the progression of molecular biology tools, the evolution of diagnostic applications, a systemic shift in the focal point of biomedical research, and an uptick in investment in biotechnology.

The market for in situ hybridization is anticipating swift expansion in the upcoming years, with its size projected to reach $2.79 billion in 2029, growing at a compound annual growth rate (CAGR) of 11.2%. Several factors, including higher incorporation in clinical diagnostics, growth in research and development funding, automated and high-throughput solutions, as well as broadened uses in neuroscience and pathology can account for this growth during the forecast period. Other contributing trends foresee improvements in molecular biology, an upswing in demand for research applications, expansion of diagnostic applications, a growing need for personalized medicine, and enhanced funding in biomedical research.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10476

What Are the Most Significant Market Trends Transforming theIn Situ Hybridization Market?

The primary players in the in situ hybridization market are focusing their resources on building cutting-edge solutions like RNA detection assays, with the hope of propelling growth in the gene therapy niche. RNA detection assays are molecular methods employed to detect and measure the presence of specific RNA molecules in a given sample. This aids in research related to gene expression, viral infections, and other phenomena related to RNA. For example, Bio-Techne Corporation, a Life Sciences company based in the United States, launched its RNAscope Plus smRNA-RNA detection assay in January 2023. This advanced in situ hybridization instrument enables concurrent fluorescent detection of tiny regulatory RNAs, like microRNAs, and three target RNAs or RNA biomarkers within the same tissue section. Offering both single-cell and subcellular resolution, this assay empowers researchers to accurately evaluate the biodistribution and effectiveness of novel gene therapies and endogenous regulatory RNAs. The assay is scalable for larger studies and is compatible with the Leica Bond Rx platform or can be used as a manual procedure. By amalgamating proprietary RNAscope and miRNAscope technologies, this assay significantly progresses our understanding of gene expression and cellular responses, providing crucial information for creating personalized gene therapies for hereditary or acquired diseases.

What Are the Top Market Players Propelling the Growth of theIn Situ Hybridization Industry?

Major companies operating in the in situ hybridization market include Thermo Fisher Scientific Inc., Bio SB Inc., BioGenex Laboratories, Advanced Cell Diagnostics Inc., Exiqon A/S, Agilent Technologies Inc., F. Hoffmann-La Roche AG, Abbott Laboratories Inc., Merck KGaA, PerkinElmer Inc., Biocare Medical LLC, Genemed Biotechnologies, Danaher Corporation, Leica Biosystems Nussloch GmbH, Bio-Rad Laboratories Inc., Oxford Gene Technology, Abnova Corporation, Qiagen, Bio-Techne Corporation, Biochain Institute Inc., Cytocell Ltd., Enzo Life Sciences Inc., Eurofins Scientific SE, FISH Technologies Sdn Bhd, Genetix Biotech Asia Pvt. Ltd., Zytomed System GmbH, Akoya Biosciences Inc., Becton Dickinson and Company (BD), DAKO Systemtechnik und Service GmbH & Co, Molecular Devices LLC., NanoString Technologies Inc., Visiopharm A/S

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/in-situ-hybridization-global-market-report

Which Primary Segments of the In Situ Hybridization Market Are Driving Growth and Industry Transformations?

The in situ hybridization market covered in this report is segmented –

1) By Product: Analytical Instruments, Kits and Reagents, Software and Services, Other Products

2) By Technique: Fluorescence In Situ Hybridization (FISH), Chromogenic In Situ hybridization (CISH)

3) By Probe: Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA)

4) By Application: Cancer, Cytogenetics, Developmental Biology, Infectious Diseases, Other Applications

5) By End Use: Research And Diagnostic Laboratories, Contract Research Organization (CROs), Academic Institutes, Other End Uses

Subsegments:

1) By Analytical Instruments: Fluorescence Microscopes, Imaging Systems, Hybridization Systems

2) By Kits and Reagents: Hybridization Kits, Detection Kits, Probes And Reagents

3) By Software and Services: Image Analysis Software, Data Management Software, Consulting And Support Services

4) By Other Products: Accessories, Control Samples, Maintenance Supplies

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=10476&type=smp

Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the In Situ Hybridization Market?# Market?

North America was the largest region in the in situ hybridization market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global in situ hybridization market during the forecast period. The regions covered in the in situ hybridization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Gobal In Situ Hybridization Maret 2025, By The Business Research Company:

Gene Expression Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/gene-expression-global-market-report

DNA And Gene Chip Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dna-and-gene-chip-global-market-report

RNA Analysis/ Transcriptomics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the in situ hybridization market?

The market size for in situ hybridization has seen significant expansion lately. It’s projected to increase from $1.68 billion in 2024 to $1.83 billion in 2025, with a compound annual growth rate (CAGR) of 8.9%. The historical growth can be tied back to the early implementation in research studies, the progression of molecular biology utilities, the creation of diagnostic applications, a shift towards biomedical research, and boosted investments in biotechnology.

What will be the in situ hybridization market size in the future?

The market size for in situ hybridization is predicted to experience accelerated expansion in the upcoming years, reaching $2.79 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 11.2%. This projected growth within the forecast period can be linked to its increased acceptance in clinical diagnostics, a surge in research and development funds, automated and high-capacity solutions, along with widened applications in neuroscience and pathology. The forecast period will exhibit significant trends which include molecular biology advancements, a burgeoning demand in research applications, the expansion of diagnostic applications, rising demand for personalised medicine, and a surge in funding for biomedical research.

Get your in situ hybridization market report here!

https://www.thebusinessresearchcompany.com/report/in-situ-hybridization-global-market-report

What main drivers are fueling expansion in the in situ hybridization market?

Expectations are for the in-situ hybridization market to expand due to the rise in infectious diseases. These diseases, which stem from contaminated food and drink as well as pathogens like bacteria, viruses, fungi, and parasites, are those that can pass from one person to another. To identify corresponding nucleic acid sequences present in the tissue, in-situ hybridization (ISH) uses nucleic acid sequences specific to the infectious agents, thereby bringing a boost to the in-situ hybridization market when infectious disease rates rise. For example, statistics from the US Centers for Disease Control and Prevention highlight this: in March 2024, tuberculosis cases increased to 9,615 from 8,320 in 2022 – that’s a rise of 1,295 cases. It is, therefore, clear to see that the upsurge in infectious diseases is fuelling the growth of the in-situ hybridization market.

What key areas define the segmentation of the global in situ hybridization market?

The in situ hybridization market covered in this report is segmented –

1) By Product: Analytical Instruments, Kits and Reagents, Software and Services, Other Products

2) By Technique: Fluorescence In Situ Hybridization (FISH), Chromogenic In Situ hybridization (CISH)

3) By Probe: Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA)

4) By Application: Cancer, Cytogenetics, Developmental Biology, Infectious Diseases, Other Applications

5) By End Use: Research And Diagnostic Laboratories, Contract Research Organization (CROs), Academic Institutes, Other End Uses

Subsegments:

1) By Analytical Instruments: Fluorescence Microscopes, Imaging Systems, Hybridization Systems

2) By Kits and Reagents: Hybridization Kits, Detection Kits, Probes And Reagents

3) By Software and Services: Image Analysis Software, Data Management Software, Consulting And Support Services

4) By Other Products: Accessories, Control Samples, Maintenance Supplies

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10476&type=smp

Who are the dominant players expanding their reach in the in situ hybridization market?

Major companies operating in the in situ hybridization market include Thermo Fisher Scientific Inc., Bio SB Inc., BioGenex Laboratories, Advanced Cell Diagnostics Inc., Exiqon A/S, Agilent Technologies Inc., F. Hoffmann-La Roche AG, Abbott Laboratories Inc., Merck KGaA, PerkinElmer Inc., Biocare Medical LLC, Genemed Biotechnologies, Danaher Corporation, Leica Biosystems Nussloch GmbH, Bio-Rad Laboratories Inc., Oxford Gene Technology, Abnova Corporation, Qiagen, Bio-Techne Corporation, Biochain Institute Inc., Cytocell Ltd., Enzo Life Sciences Inc., Eurofins Scientific SE, FISH Technologies Sdn Bhd, Genetix Biotech Asia Pvt. Ltd., Zytomed System GmbH, Akoya Biosciences Inc., Becton Dickinson and Company (BD), DAKO Systemtechnik und Service GmbH & Co, Molecular Devices LLC., NanoString Technologies Inc., Visiopharm A/S

How are evolving market trends shaping in situ hybridization Strategies?

Leading enterprises in the in situ hybridization market are pioneering new solutions including RNA detection assays, to progress the development of gene therapy. RNA detection assays are typically molecular methodologies employed to recognize and calculate the number of certain RNA molecules present in any given sample, aiding research on gene expression, viral diseases, and various other RNA-associated biological activities. As an illustration, in January 2023, Bio-Techne Corporation, an American life sciences enterprise, introduced the RNAscope Plus smRNA-RNA detection assay. This enhanced in situ hybridization instrument allows simultaneous fluorescent identification of small regulatory RNAs like microRNAs (miRNAs), and up to three target RNAs or RNA biomarkers in the same tissue slice. The assay delivers single-cell and subcellular resolution, making it easier for scientists to comprehensively evaluate the characteristics and spatial distribution of novel gene therapies and endogenous regulatory RNAs. It has the capacity to cater to sizable studies and can be used on the Leica Bond Rx platform or manually. The integration of proprietary RNAscope and miRNAscope technologies in this assay pushes forward the comprehension of gene expression and cellular responses, delivering valuable insights for the creation of bespoke gene therapies for congenital or developed diseases.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10476

Which regions are emerging as leaders in the in situ hybridization market?

North America was the largest region in the in situ hybridization market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global in situ hybridization market during the forecast period. The regions covered in the in situ hybridization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Gene Expression Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/gene-expression-global-market-report

DNA And Gene Chip Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dna-and-gene-chip-global-market-report

RNA Analysis/ Transcriptomics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Does the Projected Growth of the In Situ Hybridization Market Compare Over the Forecast Period?

In recent times, the in situ hybridization market has seen significant expansion. It is projected to increase from $1.68 billion in 2024 to $1.83 billion in 2025, experiencing a compound annual growth rate (CAGR) of 8.9%. The historical growth of this market can be accredited to early adoption for research purposes, the maturation of molecular biology instruments, the creation of diagnostic applications, shifts in focus within biomedical research, and an upswing in biotechnology investment.

The market size for in situ hybridization is predicted to experience a significant increase in the coming years, reaching “$2.79 billion in 2029 with a compound annual growth rate (CAGR) of 11.2%. The growth within this upcoming period can be linked to its growing use in clinical diagnostics, the increase in funding for research and development, the incorporation of automation and high-yield solutions, as well as broadened applications in the fields of neuroscience and pathology. Some of the key trends to keep an eye on during this period include progress in molecular biology, an uptick in demand in research applications, broadening diagnostic applications, the push for individualized medicine, and amplified funding in biomedical research.

What External and Internal Drivers Are Contributing to the Growth of the in situ hybridization Market’s Growth?

The proliferation of infectious diseases is anticipated to stimulate the in-situ hybridization market’s expansion. These diseases, which can be transmitted through contaminated food and drink and via pathogens such as viruses, bacteria, fungi, and parasites, can be identified using in-situ hybridization (ISH). ISH uses specific labeled nucleic acid sequences (probes) tied to the infectious organism to locate complementary nucleic acid sequences in the tissue. Consequently, the surge in infectious diseases enhances the growth of the in-situ hybridization market. For example, the Centers for Disease Control and Prevention, a US government agency, reported that tuberculosis cases increased by 1,295, from 8,320 in 2022 to 9,615 in 2023. Hence, the escalating prevalence of infectious diseases is propelling the expansion of the in-situ hybridization market.

Get Your Free Sample of the Global In Situ Hybridization Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=10476&type=smp

Who Are the Key Players Steering the Development of the In Situ Hybridization Market?

Major companies operating in the in situ hybridization market include:

• Thermo Fisher Scientific Inc._x000D_

• Bio SB Inc._x000D_

• BioGenex Laboratories_x000D_

• Advanced Cell Diagnostics Inc._x000D_

• Exiqon A/S_x000D_

How Are Consumer Trends Shaping the Current and Future Landscape of the In Situ Hybridization Market?

Get Instant Access to the Global In Situ Hybridization Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/in-situ-hybridization-global-market-report

What Are the Core Segments of the In Situ Hybridization Market, and How Do They Contribute to Growth?

The in situ hybridization market covered in this report is segmented –

1) By Product: Analytical Instruments, Kits and Reagents, Software and Services, Other Products

2) By Technique: Fluorescence In Situ Hybridization (FISH), Chromogenic In Situ hybridization (CISH)

3) By Probe: Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA)

4) By Application: Cancer, Cytogenetics, Developmental Biology, Infectious Diseases, Other Applications

5) By End Use: Research And Diagnostic Laboratories, Contract Research Organization (CROs), Academic Institutes, Other End Uses

Subsegments:

1) By Analytical Instruments: Fluorescence Microscopes, Imaging Systems, Hybridization Systems

2) By Kits and Reagents: Hybridization Kits, Detection Kits, Probes And Reagents

3) By Software and Services: Image Analysis Software, Data Management Software, Consulting And Support Services

4) By Other Products: Accessories, Control Samples, Maintenance Supplies

Which Geographical Regions Are Shaping the In Situ Hybridization Market Growth?

North America was the largest region in the in situ hybridization market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global in situ hybridization market during the forecast period. The regions covered in the in situ hybridization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Key Characteristics That Define the In Situ Hybridization Market?

In-situ hybridization refers to the method that enables the exact localization of a certain nucleic acid segment inside a histologic slice. In-situ hybridization is used for identifying sequences of nucleotides in tissues, including complete tissues, portions of tissues, and cells.

Browse Through More Similar Reports By The Business Research Company:

Gene Expression Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/gene-expression-global-market-report

DNA And Gene Chip Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dna-and-gene-chip-global-market-report

RNA Analysis/ Transcriptomics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: